These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 19432523)
1. Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase. Billack B; Santoro M; Lau-Cam C Microb Drug Resist; 2009 Jun; 15(2):77-83. PubMed ID: 19432523 [TBL] [Abstract][Full Text] [Related]
2. In vitro assessment of the growth and plasma membrane H Orie NN; Warren AR; Basaric J; Lau-Cam C; Piętka-Ottlik M; Młochowski J; Billack B J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28151580 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antimicrobial activity of ebselen: role of the yeast plasma membrane H+-ATPase. Chan G; Hardej D; Santoro M; Lau-Cam C; Billack B J Biochem Mol Toxicol; 2007; 21(5):252-64. PubMed ID: 17912695 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the antifungal and plasma membrane H+-ATPase inhibitory action of ebselen and two ebselen analogs in S. cerevisiae cultures. Billack B; Pietka-Ottlik M; Santoro M; Nicholson S; Młochowski J; Lau-Cam C J Enzyme Inhib Med Chem; 2010 Jun; 25(3):312-7. PubMed ID: 20210698 [TBL] [Abstract][Full Text] [Related]
5. Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Monk BC; Niimi K; Lin S; Knight A; Kardos TB; Cannon RD; Parshot R; King A; Lun D; Harding DR Antimicrob Agents Chemother; 2005 Jan; 49(1):57-70. PubMed ID: 15616276 [TBL] [Abstract][Full Text] [Related]
6. Post-antibiotic effect and post-expositional polyene antagonism of azole antifungal agents in Candida albicans: dependence on substance lipophilia. Scheven M; Scheven C; Hahn K; Senf A Mycoses; 1995; 38(11-12):435-42. PubMed ID: 8720192 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571 [TBL] [Abstract][Full Text] [Related]
8. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
9. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery. Keniya MV; Ruma YN; Tyndall JDA; Monk BC Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140 [TBL] [Abstract][Full Text] [Related]
11. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study). Swinne D; Watelle M; Van der Flaes M; Nolard N Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180 [TBL] [Abstract][Full Text] [Related]
12. Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells. Thangamani S; Eldesouky HE; Mohammad H; Pascuzzi PE; Avramova L; Hazbun TR; Seleem MN Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3002-3010. PubMed ID: 27712973 [TBL] [Abstract][Full Text] [Related]
13. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans. Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344 [TBL] [Abstract][Full Text] [Related]
15. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans. Khan MS; Malik A; Ahmad I Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200 [TBL] [Abstract][Full Text] [Related]
16. Antifungal activity of 2-(4-chlorophenyl)-1,2-benzisoselenazol-3(2H)-one, the analog of Ebselen. Bień M; Błaszczyk B; Kalinowska K; Młochowski J; Inglot AD Arch Immunol Ther Exp (Warsz); 1999; 47(3):185-93. PubMed ID: 10470446 [TBL] [Abstract][Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
19. A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12. Cao B; Tsang PW; Tsang DN; Samaranayake LP; Wang J Microbios; 1996; 87(352):161-7. PubMed ID: 9050253 [TBL] [Abstract][Full Text] [Related]
20. In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans. Mahmoud DE; Faraag AHI; Abu El-Wafa WM World J Microbiol Biotechnol; 2021 Oct; 37(11):191. PubMed ID: 34632522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]